Claims vs COA / Licensed Peptides
Licensed Peptides: claims vs COA
Website claim: 99% purity. “…team member will be happy to assist you. +1 (855) 322-2214 99%+ Purity Guaranteed per batch HPLC + Mass Spec Independent lab verif…” Source (read 2026-09-25)
139
certificates read
79 / 114
vials outside ±3% of label
26
beyond ±10% (major)
14 / 128
below advertised purity
| Product | Label → measured | Purity | Main impurity | Lab | COA |
|---|---|---|---|---|---|
| Oxytocin | 10mg → 11.08mg Overfilled +10.8% | 97.91% 1.09 pts below 99% | 2.09% not itemised | vanguard | Open |
| Oxytocin | 10mg → 11.08mg Overfilled +10.8% | 97.91% 1.09 pts below 99% | 2.09% not itemised | vanguard | Open |
| NAD+ | 500mg → 569mg Overfilled +13.8% | 98.76% 0.24 pts below 99% | 1.24% not itemised | vanguard | Open |
| NAD+ | 500mg → 569mg Overfilled +13.8% | 98.76% 0.24 pts below 99% | 1.24% not itemised | vanguard | Open |
| SS-31 | 50mg → 69.1mg Overfilled +38.2% | 98.81% 0.19 pts below 99% | 1.19% not itemised | vanguard | Open |
| SS-31 | 50mg → 69.1mg Overfilled +38.2% | 98.81% 0.19 pts below 99% | 1.19% not itemised | vanguard | Open |
| BPC-157 | BPC-157: 10mg → 11.32mg Overfilled +13.2% | 99.896% Meets 99% | 0.10% not itemised | janoshik | Open |
| BPC-157 | 5mg → 5.94mg Overfilled +18.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Cagrilintide | 5mg → 5.59mg Overfilled +11.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| DSIP | 5mg → 4.72mg Under label -5.6% | 98.82% 0.18 pts below 99% | 1.18% not itemised | vanguard | Open |
| DSIP | 5mg → 4.72mg Under label -5.6% | 98.82% 0.18 pts below 99% | 1.18% not itemised | vanguard | Open |
| Epithalon | 10mg → 11.16mg Overfilled +11.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-3 R | 5mg → 5.61mg Overfilled +12.2% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP3-R | 20mg → 22.77mg Overfilled +13.9% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP3-R | GLP3-R: 40mg → 44.33mg Overfilled +10.8% | 99.72% Meets 99% | 0.28% not itemised | janoshik | Open |
| GLP3-R | 5mg → 5.77mg Overfilled +15.4% | 99.65% Meets 99% | 0.35% not itemised | janoshik | Open |
| GLP3-R | 10mg → 11.39mg Overfilled +13.9% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP3-R | GLP3-R: 30mg → 34.08mg Overfilled +13.6% | 99.664% Meets 99% | 0.34% not itemised | janoshik | Open |
| GLP3-R | 50mg → 59.11mg Overfilled +18.2% | 99.5% Meets 99% | 0.50% not itemised | vanguard | Open |
| GLP3-R | 5mg → 5.77mg Overfilled +15.4% | 99.65% Meets 99% | 0.35% not itemised | vanguard | Open |
| GLP3-R | 10mg → 11.06mg Overfilled +10.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP3-R | 60mg → 70.02mg Overfilled +16.7% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Melanotan 2 | 10mg → 11.21mg Overfilled +12.1% | 99.23% Meets 99% | 0.77% not itemised | vanguard | Open |
| Melanotan 2 | 10mg → 11.21mg Overfilled +12.1% | 99.23% Meets 99% | 0.77% not itemised | vanguard | Open |
| NAD+ | 500mg → 454mg Under label -9.2% | 98% 1.00 pts below 99% | 2.00% not itemised | vanguard | Open |
| Pinealon | 10mg → 8.03mg Underfilled -19.7% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Pinealon | 10mg → 8.03mg Underfilled -19.7% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Sermorelin | 5mg → 5.25mg Over label +5.0% | 98.36% 0.64 pts below 99% | 1.64% not itemised | vanguard | Open |
| Sermorelin | 5mg → 5.25mg Over label +5.0% | 98.36% 0.64 pts below 99% | 1.64% not itemised | vanguard | Open |
| Thymosin Alpha-1 | 5mg → 5.96mg Overfilled +19.2% | 99.13% Meets 99% | 0.87% not itemised | vanguard | Open |
| Thymosin Alpha-1 | 5mg → 5.96mg Overfilled +19.2% | 99.13% Meets 99% | 0.87% not itemised | vanguard | Open |
| 5-Amino-1MQ | 5mg → 5.39mg Over label +7.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| AOD-9604 | 5mg → 4.77mg Under label -4.6% | 99.21% Meets 99% | 0.79% not itemised | vanguard | Open |
| AOD-9604 | 5mg → 4.77mg Under label -4.6% | 99.21% Meets 99% | 0.79% not itemised | vanguard | Open |
| BPC 157 30mg | 30mg → 32.12mg Over label +7.1% | — | — | ethos-analytics | Open |
| BPC 157 30mg | 30mg → 32.12mg Over label +7.1% | — | — | ethos-analytics | Open |
| BPC-157 | 10mg → 10.58mg Over label +5.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| BPC-157 | 10mg → 10.58mg Over label +5.8% | 99.8% Meets 99% | 0.20% not itemised | vanguard | Open |
| BPC/TB 30mg/30mg | BPC-157: 30mg → 31.87mg Over label +6.2% TB-500: 30mg → 31.41mg Over label +4.7% | — | — | ethos-analytics | Open |
| BPC/TB 30mg/30mg | BPC-157: 30mg → 31.87mg Over label +6.2% TB-500: 30mg → 31.41mg Over label +4.7% | — | — | ethos-analytics | Open |
| CJC-1295 | 5mg → 5.37mg Over label +7.4% | 99.22% Meets 99% | 0.78% not itemised | vanguard | Open |
| CJC-1295 | 10mg → 9.68mg Under label -3.2% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| CJC-1295 | 5mg → 5.37mg Over label +7.4% | 99.22% Meets 99% | 0.78% not itemised | vanguard | Open |
| Cagrilintide | 10mg → 9.46mg Under label -5.4% | 99.18% Meets 99% | 0.82% not itemised | vanguard | Open |
| Epithalon | 50mg → 54.7mg Over label +9.4% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-2 T | 40mg → 38.67mg Under label -3.3% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-2 T | 45mg → 41.67mg Under label -7.4% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-2 T | 60mg → 57.87mg Under label -3.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-2T | 10mg → 10.7mg Over label +7.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-2T | 10mg → 10.7mg Over label +7.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-3 R | 30mg → 32.04mg Over label +6.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-3 R | 40mg → 43.73mg Over label +9.3% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-3 R | 60mg → 62.71mg Over label +4.5% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-3R | 30mg → 28.92mg Under label -3.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP2-T | 10mg → 10.89mg Over label +8.9% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP2-T | 15mg → 15.53mg Over label +3.5% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP3-R | 40mg → 42.24mg Over label +5.6% | 99.79% Meets 99% | 0.21% not itemised | vanguard | Open |
| GLP3-R | GLP3-R: 10mg → 10.76mg Over label +7.6% | 99.71% Meets 99% | 0.29% not itemised | janoshik | Open |
| GLP3-R | 15mg → 16.18mg Over label +7.9% | 99.03% Meets 99% | 0.97% not itemised | vanguard | Open |
| GLP3-R | 30mg → 32.7mg Over label +9.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP3-R | GLP3-R: 50mg → 54.93mg Over label +9.9% | 99.79% Meets 99% | 0.21% not itemised | janoshik | Open |
| GLP3-R | 10mg → 10.74mg Over label +7.4% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP3-R | 40mg → 43.52mg Over label +8.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| IGF-1 LR3 | Not measured | 98.04% 0.96 pts below 99% | 1.96% not itemised | vanguard | Open |
| Ipamorelin | 10mg → 10.75mg Over label +7.5% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Kisspeptin | 10mg → 9.49mg Under label -5.1% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| MOTS-C | 10mg → 11mg Over label +10.0% | 99.08% Meets 99% | 0.92% not itemised | vanguard | Open |
| MOTS-C | 10mg → 11mg Over label +10.0% | 99.08% Meets 99% | 0.92% not itemised | vanguard | Open |
| MOTS-¢ | 10mg → 10.63mg Over label +6.3% | 99.41% Meets 99% | 0.59% not itemised | vanguard | Open |
| Melanotan 1 | 10mg → 10.88mg Over label +8.8% | 99.57% Meets 99% | 0.43% not itemised | vanguard | Open |
| Melanotan 1 | 10mg → 10.88mg Over label +8.8% | 99.57% Meets 99% | 0.43% not itemised | vanguard | Open |
| Melanotan 2 | Not measured | 98.7% 0.30 pts below 99% | 1.30% not itemised | vanguard | Open |
| Melanotan 2 | 10mg → 9.86mg On label -1.4% | 98.7% 0.30 pts below 99% | 1.30% not itemised | vanguard | Open |
| NAD 1500mg (6-8mg per spray) | 1500mg → 1597.34mg Over label +6.5% | — | — | ethos-analytics | Open |
| SS-31 | 10mg → 10.88mg Over label +8.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Selank | 10mg → 9.42mg Under label -5.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Selank | 10mg → 9.42mg Under label -5.8% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Selank Nasal 40mg | 40mg → 41.79mg Over label +4.5% | — | — | ethos-analytics | Open |
| Selank Nasal 40mg | 40mg → 41.79mg Over label +4.5% | — | — | ethos-analytics | Open |
| Semax Nasal 50mg | 50mg → 52.47mg Over label +4.9% | — | — | ethos-analytics | Open |
| Semax Nasal 50mg | 50mg → 52.47mg Over label +4.9% | — | — | ethos-analytics | Open |
| Tesamorelin | 10mg → 10.92mg Over label +9.2% | 99.17% Meets 99% | 0.83% not itemised | vanguard | Open |
| BPC-157/TB-4 | Blend, per-component content not listed | 99.5% Meets 99% | 0.50% not itemised | vanguard | Open |
| BPC-157/TB-4 | Blend, per-component content not listed | >99.5% Meets 99% | under 0.50% not itemised | vanguard | Open |
| BPC-157/TB-500 | Blend, per-component content not listed | 99.04% Meets 99% | 0.96% not itemised | vanguard | Open |
| BPC-157/TB-500 | Blend, per-component content not listed | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| CJC-1295 | 5mg → 4.96mg On label -0.8% | 99.73% Meets 99% | 0.27% not itemised | vanguard | Open |
| CJC-1295 | 5mg → 4.96mg On label -0.8% | 99.73% Meets 99% | 0.27% not itemised | vanguard | Open |
| CJC-1295 no DAC/Ipamorelin | Blend, per-component content not listed | 99.05% Meets 99% | 0.95% not itemised | vanguard | Open |
| CJC-1295 no DAC/Ipamorelin | Blend, per-component content not listed | 99.05% Meets 99% | 0.95% not itemised | vanguard | Open |
| CJC-1295/Ipamorelin | Blend, per-component content not listed | 99.1% Meets 99% | 0.90% not itemised | vanguard | Open |
| CJC-1295/Ipamorelin | Blend, per-component content not listed | 99.1% Meets 99% | 0.90% not itemised | vanguard | Open |
| Cagrilintide | Not measured | 99.05% Meets 99% | 0.95% not itemised | vanguard | Open |
| Cagrilintide | Not measured | 99.05% Meets 99% | 0.95% not itemised | vanguard | Open |
| GHK-Cu | 100mg → 99.4mg On label -0.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GHK-Cu | 50mg → 50.98mg On label +2.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GHK-Cu | 50mg → 50.98mg On label +2.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLOW | Blend, per-component content not listed | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLOW | Blend, per-component content not listed | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLOW | Blend, per-component content not listed | >99% Meets 99% | under 1.00% not itemised | vanguard | Open |
| GLP-2 T | 50mg → 48.54mg On label -2.9% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-3 IR | 20mg → 19.67mg On label -1.7% | 99.12% Meets 99% | 0.88% not itemised | vanguard | Open |
| GLP-3 R | 20mg → 20.19mg On label +1.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-3R | 40mg → 40.8mg On label +2.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP-3R | 40mg → 40.8mg On label +2.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP2-T | 20mg → 19.81mg On label -1.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP2-T | 30mg → 30.31mg On label +1.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP2-T | 5mg → 5.15mg On label +3.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP2-T | 5mg → 5.15mg On label +3.0% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| GLP3-R | 20mg → 19.67mg On label -1.7% | 99.12% Meets 99% | 0.88% not itemised | vanguard | Open |
| IGF1 LR3 | Not measured | 99.03% Meets 99% | 0.97% not itemised | vanguard | Open |
| Ipamorelin | 5mg → 5.03mg On label +0.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| KLOW | Blend, per-component content not listed | >99% Meets 99% | under 1.00% not itemised | vanguard | Open |
| KPV | 10mg → 10.21mg On label +2.1% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Kisspeptin-10 | 5mg → 5.03mg On label +0.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Kisspeptin-10 | 5mg → 5.03mg On label +0.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| MOTS-C | 40mg → 39.71mg On label -0.7% | 99.16% Meets 99% | 0.84% not itemised | vanguard | Open |
| MOTS-c | Not measured | 99.41% Meets 99% | 0.59% not itemised | vanguard | Open |
| MT1 | 10mg → 9.99mg On label -0.1% | 99.28% Meets 99% | 0.72% not itemised | vanguard | Open |
| MT1 | 10mg → 9.99mg On label -0.1% | 99.28% Meets 99% | 0.72% not itemised | vanguard | Open |
| NAD+ | Not measured | 99.8% Meets 99% | 0.20% not itemised | vanguard | Open |
| PT 141 30mg | 30mg → 30.87mg On label +2.9% | — | — | ethos-analytics | Open |
| PT 141 30mg | 30mg → 30.87mg On label +2.9% | — | — | ethos-analytics | Open |
| PT-141 | 10mg → 10.15mg On label +1.5% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Semax | 30mg → 30.66mg On label +2.2% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Semax | 30mg → 30.66mg On label +2.2% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Sermorelin | 10mg → 10.16mg On label +1.6% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Sermorelin | 5mg → 4.96mg On label -0.8% | 99.04% Meets 99% | 0.96% not itemised | vanguard | Open |
| Sermorelin | 5mg → 4.96mg On label -0.8% | 99.04% Meets 99% | 0.96% not itemised | vanguard | Open |
| TB-500 | 10mg → 10.05mg On label +0.5% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Tesamorelin | 10mg → 10.05mg On label +0.5% | >99.8% Meets 99% | under 0.20% not itemised | vanguard | Open |
| Tesamorelin | Not measured | 99.17% Meets 99% | 0.83% not itemised | vanguard | Open |
| Tesamorelin/Ipamorelin | Blend, per-component content not listed | 99.04% Meets 99% | 0.96% not itemised | vanguard | Open |
| Tesamorelin/Ipamorelin | Blend, per-component content not listed | 99.04% Meets 99% | 0.96% not itemised | vanguard | Open |
| Tesamorelin/Ipamorelin | Blend, per-component content not listed | 99.04% Meets 99% | 0.96% not itemised | vanguard | Open |
| Tesamorelin/Ipamorelin | Blend, per-component content not listed | 99.02% Meets 99% | 0.98% not itemised | vanguard | Open |
| Tesamorelin/Ipamorelin | Blend, per-component content not listed | 99.02% Meets 99% | 0.98% not itemised | vanguard | Open |
| Thymosin | 5mg → 4.9mg On label -2.0% | 99.07% Meets 99% | 0.93% not itemised | vanguard | Open |
| Thymosin | 5mg → 4.9mg On label -2.0% | 99.07% Meets 99% | 0.93% not itemised | vanguard | Open |
How this is checked
- Vial content. Measured net peptide content against the size on the label. Within ±3% is on label, 3–10% is off label, beyond ±10% is a major deviation (under- or overfilled). When a certificate weighs several vials of the batch, the vial farthest from the label is the one judged, and with several purity results the lowest counts. Blends are only checked when the certificate lists each component.
- Purity. HPLC purity on each certificate against the purity the supplier promises site-wide on its own website. Up to 1 point below the claim is amber, more than that is red. Only a direct promise counts (“99%+ purity guaranteed”); explanations of what purity means, one product's figure and page code are not treated as a claim. A certificate that reports only a bound (“>99%”) is judged only when the bound meets the claim, and a specification line is never read as a result.
- Whose certificate. A certificate is only read once our client-identity review has looked at it, and one issued to a different company is left out — whether the automatic check or a manual review found it. A certificate issued to the company that runs the supplier's own website counts as the supplier's. A file hosted on another supplier's website is not counted for this one. The same rules decide which certificates appear on supplier and product pages. Only peptide certificates are read: bacteriostatic water, acetic acid and other diluents are left out, and so are product data sheets, which state a specification rather than a batch result.
- Main impurity. Shown when the certificate itemises it: a named impurity (TFA, deletion sequence, oxidation…) or the largest secondary peak in the HPLC peak table. Most certificates report only a purity figure, so the rest of the sample is not itemised.
- Trust Score. These checks are 10 of the 25 Transparency points: vial content 7 (full credit within ±3%, half up to ±10%, none beyond, over- and underfilled alike), purity 3 (98% is the bar when a supplier advertises no figure). Fewer than 5 readable results gives half credit rather than a guess.
- These are the supplier's own published certificates, read automatically from the PDF or image. Janoshik results tables are read twice from the image, cell by cell, and a figure the two readings disagree on is left out rather than guessed. A certificate covers one batch on one date. We have not tested these batches ourselves.